We develop and produce highly specialized targeted investor and business development conferences exclusively for the biopharmaceutical and life sciences industries.
Demy-Colton has been closely monitoring developments around Covid-19 and, for the safety of our attendees and staff, we have made the decision to postpone BioFuture and cancel the 2020 edition of Biotech CEO Summit Europe. We are evaluating the execution of Biotech CEO Summit Napa at this time.
Demy-Colton wants to thank everyone that has been, and who will be, involved in our programs. Your ongoing support is invaluable to creating the types of gatherings that add significant value to the overall healthcare ecosystem. We thank every company in our extraordinary network for the work you do every day.
Demy-Colton also wants to acknowledge the hard work and commitment of everyone who is working selflessly to end this pandemic and save lives.
We have compiled a COVID-19 resource page that we hope you will find useful.
With over 20 years’ experience connecting leaders of innovative biotech companies with key stakeholders, investors and advisors, we create ideal environments to examine and address opportunities and challenges in today’s biotech industry.
Get to know us, a respected leader in biotech investor conferences and highly targeted leadership events.
Who we are ⇢
See how we create communities that foster lasting and mutually beneficial relationships.
What we do ⇢
How innovation is shaping the biopharmaceutical industry.
What we think ⇢
